Terms: = Lymphoma AND NPM1, NPM, 4869, ENSG00000181163, P06748, B23, MGC104254
597 results:
1. Liquid biopsy-based circulating tumour (ct)DNA analysis of a spectrum of myeloid and lymphoid malignancies yields clinically actionable results.
Mata DA; Lee JK; Shanmugam V; Marcus CB; Schrock AB; Williams EA; Ritterhouse LL; Hickman RA; Janovitz T; Patel NR; Kroger BR; Ross JS; Mirza KM; Oxnard GR; Vergilio JA; Elvin JA; Benhamida JK; Decker B; Xu ML
Histopathology; 2024 Jun; 84(7):1224-1237. PubMed ID: 38422618
[TBL] [Abstract] [Full Text] [Related]
2. Expansion of targeted degradation by Gilteritinib-Warheaded PROTACs to ALK fusion proteins.
Yokoo H; Tsuji G; Inoue T; Naito M; Demizu Y; Ohoka N
Bioorg Chem; 2024 Apr; 145():107204. PubMed ID: 38377822
[TBL] [Abstract] [Full Text] [Related]
3. Molecular Screening in Anaplastic lymphoma Kinase-Positive Anaplastic Large Cell lymphoma: Anaplastic lymphoma Kinase Analysis, Next-Generation Sequencing Fusion Gene Detection, and T-Cell Receptor Immunoprofiling.
Kalinova M; Mrhalova M; Kabickova E; Svaton M; Skotnicova A; Prouzova Z; Krenova Z; Kolenova A; Divoka M; Fronkova E; Kodet R
Mod Pathol; 2024 Mar; 37(3):100428. PubMed ID: 38266918
[TBL] [Abstract] [Full Text] [Related]
4. CCDC86 promotes the aggressive behavior of nasopharyngeal carcinoma by positively regulating EGFR and activating the PI3K/Akt signaling.
Wang Z; Zhou T; Chen X; Zhu X; Liao B; Liu J; Li S; Tan T; Liu Y
Neoplasma; 2023 Dec; 70(6):761-776. PubMed ID: 38247332
[TBL] [Abstract] [Full Text] [Related]
5. Proteomics analysis identifies the ribosome associated coiled-coil domain-containing protein-124 as a novel interaction partner of nucleophosmin-1.
Çakırca G; Öztürk MT; Telkoparan-Akillilar P; Güllülü Ö; Çetinkaya A; Tazebay UH
Biol Cell; 2024 Jan; 116(1):e202300049. PubMed ID: 38029384
[TBL] [Abstract] [Full Text] [Related]
6. SOHO State of the Art Updates and Next Questions: Understanding and Overcoming Venetoclax Resistance in Hematologic Malignancies.
Forsberg M; Konopleva M
Clin Lymphoma Myeloma Leuk; 2024 Jan; 24(1):1-14. PubMed ID: 38007372
[TBL] [Abstract] [Full Text] [Related]
7. The acetylation of STAT3 at K685 attenuates npm-ALK-induced tumorigenesis.
Korai A; Lin X; Tago K; Funakoshi-Tago M
Cell Signal; 2024 Feb; 114():110985. PubMed ID: 38000524
[TBL] [Abstract] [Full Text] [Related]
8. Chimeric kinase ALK induces expression of NAMPT and selectively depends on this metabolic enzyme to sustain its own oncogenic function.
Zhang Q; Basappa J; Wang HY; Nunez-Cruz S; Lobello C; Wang S; Liu X; Chekol S; Guo L; Ziober A; Nejati R; Shestov A; Feldman M; Glickson JD; Turner SD; Blair IA; Van Dang C; Wasik MA
Leukemia; 2023 Dec; 37(12):2436-2447. PubMed ID: 37773266
[TBL] [Abstract] [Full Text] [Related]
9. Nuclear npm-ALK Protects Myc from Proteasomal Degradation and Contributes to Its High Expression in Cancer Stem-Like Cells in ALK-Positive Anaplastic Large Cell lymphoma.
Shang C; Lai J; Haque M; Chen W; Wang P; Lai R
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762644
[TBL] [Abstract] [Full Text] [Related]
10. Real-world genomic testing and treatment patterns of newly diagnosed adult acute myeloid leukemia patients within a comprehensive health system.
Byrd JC; Gatz JL; Louis CL; Mims AS; Borate U; Yocum AO; Gana TJ; Burd A
Cancer Med; 2023 Sep; 12(17):18368-18380. PubMed ID: 37635639
[TBL] [Abstract] [Full Text] [Related]
11. A novel subclonal rearrangement of the STRN3::PDGFRB gene in de novo acute myeloid leukemia with npm1 mutation and its leukemogenic effects.
Wang Z; Liu T; Liu W; Gao X; Wan L; Qiu S; Song Y; Gu R; Tian Z; Wang M; Wang J; Mi Y; Wei S
Cancer Gene Ther; 2023 Nov; 30(11):1471-1484. PubMed ID: 37550570
[TBL] [Abstract] [Full Text] [Related]
12. Samples from patients with AML show high concordance in detection of mutations by NGS at local institutions vs central laboratories.
Borate U; Yang F; Press R; Ruppert AS; Jones D; Caruthers S; Zhao W; Vergilio JA; Pavlick DC; Juckett L; Norris B; Bucy T; Burd A; Stein EM; Patel P; Baer MR; Stock W; Schiller G; Blum W; Kovacsovics T; Litzow M; Foran J; Heerema NA; Rosenberg L; Marcus S; Yocum A; Stefanos M; Druker B; Byrd JC; Levine RL; Mims A
Blood Adv; 2023 Oct; 7(20):6048-6054. PubMed ID: 37459200
[TBL] [Abstract] [Full Text] [Related]
13. Phosphoproteome analysis of cerebrospinal fluid extracellular vesicles in primary central nervous system lymphoma.
Deng Y; Li Q; Sun J; Ma L; Ding Y; Cai Y; Iliuk A; Chen B; Xie Z; Tao WA
Analyst; 2023 Jul; 148(15):3594-3602. PubMed ID: 37403840
[TBL] [Abstract] [Full Text] [Related]
14. Discovery of a miniaturized PROTAC with potent activity and high selectivity.
Gong L; Li R; Gong J; Ning X; Sun J; Ma Q; Zhu C; Yang Y; Lin K; Li Y; Zhang Q; Li T; Lin Z
Bioorg Chem; 2023 Jul; 136():106556. PubMed ID: 37105002
[TBL] [Abstract] [Full Text] [Related]
15. Myeloid sarcoma with
Ramia de Cap M; Wu LP; Hirt C; Pihan GA; Patel SS; Tam W; Bueso-Ramos CE; Kanagal-Shamanna R; Raess PW; Siddon A; Narayanan D; Morgan EA; Pinkus GS; Mason EF; Hsi ED; Rogers HJ; Toth L; Foucar K; Hurwitz SN; Bagg A; Rets A; George TI; Orazi A; Arber DA; Hasserjian RP; Weinberg OK;
Leuk Lymphoma; 2023 May; 64(5):972-980. PubMed ID: 36960680
[TBL] [Abstract] [Full Text] [Related]
16. Wilms' tumor 1 expression combined with genetic mutations for prognostic assessment in MDS.
Pan D; Zhao W; Jiang Q; Yin C; He H; Liao L; Ye J; Dai M
Leuk Lymphoma; 2023 Apr; 64(4):856-864. PubMed ID: 36905177
[TBL] [Abstract] [Full Text] [Related]
17. Direct interaction between mortalin and HIF-1α at the mitochondria inhibits apoptosis by blocking recruitment of Bax.
Yfantis A; Mylonis I; Simos G
FEBS J; 2023 Aug; 290(15):3764-3780. PubMed ID: 36825991
[TBL] [Abstract] [Full Text] [Related]
18. Outcome prediction by the 2022 European LeukemiaNet genetic-risk classification for adults with acute myeloid leukemia: an Alliance study.
Mrózek K; Kohlschmidt J; Blachly JS; Nicolet D; Carroll AJ; Archer KJ; Mims AS; Larkin KT; Orwick S; Oakes CC; Kolitz JE; Powell BL; Blum WG; Marcucci G; Baer MR; Uy GL; Stock W; Byrd JC; Eisfeld AK
Leukemia; 2023 Apr; 37(4):788-798. PubMed ID: 36823396
[TBL] [Abstract] [Full Text] [Related]
19. SBNO2 is a critical mediator of STAT3-driven hematological malignancies.
Brandstoetter T; Schmoellerl J; Grausenburger R; Kollmann S; Doma E; Huuhtanen J; Klampfl T; Eder T; Grebien F; Hoermann G; Zuber J; Mustjoki S; Maurer B; Sexl V
Blood; 2023 Apr; 141(15):1831-1845. PubMed ID: 36630607
[TBL] [Abstract] [Full Text] [Related]
20. The Latest Breakthroughs in Immunotherapy for Acute Myeloid Leukemia, with a Special Focus on NKG2D Ligands.
Maurer S; Zhong X; Prada BD; Mascarenhas J; de Andrade LF
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555547
[TBL] [Abstract] [Full Text] [Related]
[Next]
